Immuno-cytometric detection of circulating cell free methylated DNA, post-translationally modified histones and micro RNAs using semi-conducting nanocrystals.

Circulating epigenomic signatures Circulating nucleic acids Immuno assay Nano-biosensor Translational research

Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
15 Jan 2021
Historique:
received: 25 03 2020
revised: 17 07 2020
accepted: 22 07 2020
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 15 5 2021
Statut: ppublish

Résumé

The diagnostic potential of cell free epigenomic signatures is largely driven by the fact that manifold quantities of methylated DNA, post-translationally modified histones and micro RNAs are released into systemic circulation in various non-communicable diseases. However, the time-consuming and specificity-related complications of conventional analytical procedures necessitate the development of a method which is rapid, selective and sensitive in nature. The present work illustrates a novel; prompt; "mix and measure" cytometric-based nano-biosensing system that offers direct quantification of cell-free circulating (ccf) epigenomic signatures (methylated ccf-DNA, tri-methylated histone H3 at lysine {4, 9, 27 & 36} and argonaute 2 protein-bound ccf-micro RNAs) using triple nano-assemblies in a single tube format. Each assembly with unique structural and spectral properties comprised of n-type semiconducting nanocrystals conjugated to a specific monoclonal antibody. Our results suggested that the developed combinatorial approach may offer simultaneous detection of three distinct yet biologically interrelated signatures with high selectivity and sensitivity using flow cytometry and fluorometry in the enriched and test samples. The proposed novel nano-assembly based detection system has a considerable potential of emerging as a minimal invasive easy-to-use method that could possibly permit real-time, rapid and reproducible monitoring of epigenomic markers in clinical and field settings.

Identifiants

pubmed: 33167226
pii: S0039-9140(20)30807-9
doi: 10.1016/j.talanta.2020.121516
pii:
doi:

Substances chimiques

Histones 0
MicroRNAs 0
DNA 9007-49-2
Lysine K3Z4F929H6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121516

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Ruchita Shandilya (R)

Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India.

Neha Bunkar (N)

Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India.

Roshani Kumari (R)

Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India.

Arpit Bhargava (A)

Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India.

Koel Chaudhury (K)

School of Medical Science & Technology, Indian Institute of Technology, Kharagpur, India.

Irina Yu Goryacheva (IY)

Department of General and Inorganic Chemistry, Saratov State University, Saratov, Russia.

Pradyumna Kumar Mishra (PK)

Department of Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, India. Electronic address: pkm_8bh@yahoo.co.uk.

Articles similaires

Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition

The significance of miR-124 in the diagnosis and prognosis of glioma: A systematic review.

Elham Ghasemi, Mahdieh Mondanizadeh, Amir Almasi-Hashiani et al.
1.00
Humans MicroRNAs Glioma Prognosis Biomarkers, Tumor
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals

Classifications MeSH